Athanasios Gaitatzis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Athanasios Gaitatzis has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Josemir Wanderley Sander
Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology London UK
13 shared publications - Azeem Majeed
Faculty of Medicine, Imperial College London, London, UK
4 shared publications A L Johnson
MRC Biostatistics Unit, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge, CB2 2SR, UK
1 shared publicationA. L. Johnson
From the Department of Clinical & Experimental Epilepsy (G.S.B., A.G., J.W.S.), UCL Institute of Neurology, and National Hospital for Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust, Queen Square, London; Bristol Medical School (C.L.B.); MRC Biostatistics Unit (A.L.J.), Institute of Public Health, University Forvie Site, Cambridge, UK; and SEIN–Epilepsy Institutes of the Netherlands Foundation (J.W.S.), The Netherlands
1 shared publicationAlexandra Seewann
Curtin Medical School Perth Western Australia Australia
1 shared publication- Allan G. Kermode
University of Western Australia
1 shared publication
Latest Publications
- 10 October 2026
- Published by Wiley in Epileptic Disorders
Taking a clinical history in adolescents and adults presenting with seizures or epilepsy
Despite advances in EEG, neuroimaging, and other diagnostic technologies, a carefully obtained clinical history remains the cornerstone of diagnosis, classification, and treatment planning. However, structured guidance on history‐taking that integrates state‐of‐the‐art evidence and the updated 2025 International League Against Epilepsy (ILAE) seizure classification is limited. We performed a review of evidence published between January 2000 and April 2026, supplemented by landmark earlier studies, ILAE position papers, and National Institute for Health and Care Excellence (NICE) guidelines. Evidence was synthesized to develop a practical framework for obtaining and interpreting the clinical history in adolescents and adults presenting with a first seizure, recurrent seizures, or established epilepsy. We present a structured approach that follows the sequence of a clinical consultation, encompassing the presenting complaint, detailed event reconstruction, semiology, collateral witness accounts, smartphone video recordings, seizure triggers and temporal patterns, past medical history, medication review, family history, social factors, and safety issues. We discuss the diagnostic value of individual history elements, practical strategies for distinguishing epileptic seizures from functional/dissociative seizures and syncope, and the contribution of history‐taking to seizure classification under the updated 2025 ILAE framework. We also summarize clinically relevant risk factors, comorbidities, and management implications that influence diagnostic accuracy and individualized care. Practical diagnostic questionnaires are provided to facilitate differential diagnosis and seizure classification, particularly for clinicians without specialist epilepsy expertise. A systematic clinical history, obtained from the individual and eyewitnesses and complemented by video recordings when available, remains the single most important diagnostic tool in epilepsy. Structured history‐taking improves diagnostic accuracy, reduces misdiagnosis, supports accurate seizure classification, guides appropriate investigations, and provides the foundation for personalized management. This practical framework offers an evidence‐based approach that can be readily incorporated into routine clinical practice and education across diverse healthcare settings.
- 10 October 2026
- Published by Wiley in Epileptic Disorders
Taking a clinical history in adolescents and adults presenting with seizures or epilepsy
Despite advances in EEG, neuroimaging, and other diagnostic technologies, a carefully obtained clinical history remains the cornerstone of diagnosis, classification, and treatment planning. However, structured guidance on history‐taking that integrates state‐of‐the‐art evidence and the updated 2025 International League Against Epilepsy (ILAE) seizure classification is limited. We performed a review of evidence published between January 2000 and April 2026, supplemented by landmark earlier studies, ILAE position papers, and National Institute for Health and Care Excellence (NICE) guidelines. Evidence was synthesized to develop a practical framework for obtaining and interpreting the clinical history in adolescents and adults presenting with a first seizure, recurrent seizures, or established epilepsy. We present a structured approach that follows the sequence of a clinical consultation, encompassing the presenting complaint, detailed event reconstruction, semiology, collateral witness accounts, smartphone video recordings, seizure triggers and temporal patterns, past medical history, medication review, family history, social factors, and safety issues. We discuss the diagnostic value of individual history elements, practical strategies for distinguishing epileptic seizures from functional/dissociative seizures and syncope, and the contribution of history‐taking to seizure classification under the updated 2025 ILAE framework. We also summarize clinically relevant risk factors, comorbidities, and management implications that influence diagnostic accuracy and individualized care. Practical diagnostic questionnaires are provided to facilitate differential diagnosis and seizure classification, particularly for clinicians without specialist epilepsy expertise. A systematic clinical history, obtained from the individual and eyewitnesses and complemented by video recordings when available, remains the single most important diagnostic tool in epilepsy. Structured history‐taking improves diagnostic accuracy, reduces misdiagnosis, supports accurate seizure classification, guides appropriate investigations, and provides the foundation for personalized management. This practical framework offers an evidence‐based approach that can be readily incorporated into routine clinical practice and education across diverse healthcare settings.
- 11 December 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 175, 110829
Health risk factors and polypharmacy in people with epilepsy and their association with multimorbidity: a single centre retrospective study
- 11 December 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 175, 110829
Health risk factors and polypharmacy in people with epilepsy and their association with multimorbidity: a single centre retrospective study
- 18 June 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 172, 110547
Multimorbidity in adults with epilepsy attending an outpatient epilepsy clinic
- 18 June 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 172, 110547
Multimorbidity in adults with epilepsy attending an outpatient epilepsy clinic
- 29 March 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 107, 136-145
Multimorbidity in people with epilepsy
- 29 March 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 107, 136-145
Multimorbidity in people with epilepsy
- 24 March 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (12) , e89
Teaching Video Neuro Images : An adult patient with rhythmic movement disorder
- 24 March 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (12) , e89
Teaching Video Neuro Images : An adult patient with rhythmic movement disorder
- 17 March 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (11) , e83-4
Teaching Video Neuro Images : Frontal opercular seizures with jacksonian march
- 17 March 2015
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (11) , e83-4
Teaching Video Neuro Images : Frontal opercular seizures with jacksonian march
- 1 September 2014
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 23 (8) , 657-661
Association of primary care factors with hospital admissions for epilepsy in England, 2004–2010: National observational study
- 1 September 2014
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 23 (8) , 657-661
Association of primary care factors with hospital admissions for epilepsy in England, 2004–2010: National observational study
- 22 April 2014
- Vol. 82 (16) , 1480
Author response.
- 9 October 2013
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 84 (11) , e2.173-e2
THE VALUE OF EEG IN THE INVESTIGATION OF UNEXPLAINED SYNCOPE IN A GENERAL HOSPITAL POPULATION
Background Many physicians request EEG in order to differentiate between syncope and seizure in individuals presenting with transient loss of consciousness (TLOC). This is particularly the case in people taken to hospital following a collapse, where a witness account is not always available. Purpose We aim to investigate the usefulness of EEG in the assessment of unexplained TLOC in a large, unselected group of patients presenting in an emergency department. We also assess the risk of seizure development and clinical course following initial presentation. Methods We retrospectively reviewed referral forms of all routine and urgent EEGs performed at Sir Charles Gairdner Hospital, Perth, Western Australia between April 2010 to November 2011 to identify recordings performed for the investigation of suspected syncope or TLOC. Cases with identifiable cause at initial assessment, and cases suggestive of seizure, previous diagnosis of epilepsy and falls without loss of consciousness were excluded. Diagnosis at discharge and EEG reports were obtained through electronic patient records, EEG archive, and case notes as required. EEGs were classified as normal, abnormal (non–epileptiform abnormalities only), and showing definite epileptiform discharges (EDs). Detailed clinical information including subsequent development of seizures or death was collected for a subgroup of patients with 1–year follow–up after first presentation across all hospitals in the greater Perth area through health electronic linkage. General practitioners and patients were also contacted in order to obtain additional information as needed. The death rate and standardised mortality ratio (SMR) were calculated according to standard methods based on life table 2008–2010 of the Australian Bureau of Statistics. Results We identified 197 cases with unexplained TLOC (age range 18–98 years). No further clinical information was available for 11 cases. The EEG was abnormal in 1/3 of all cases, and in 50% of those over 65 years. EDs were identified in 2 patients (1%); of those, a diagnosis of seizure was made in one patient who was subsequently started on antiepileptic treatment, with no final diagnosis made in the other. Diagnosis at discharge was made in 129 cases (65%) with 23 (18%) of those receiving a seizure diagnosis. The 1–year follow up group consisted of 82 patients (age range 20–95 years); 52 (63%) people were multimorbid (defined as having ≥2 conditions). None of the patients without a seizure diagnosis presented with seizures during follow–up. During this period there were 11 deaths (age range 30–94 years), all in multimorbid people, and none in people with seizure diagnosis. The case fatality rate was 13.4% and SMR 4.27 (95% Fisher's exact CI, 2.13–7.42). Discussion This study demonstrates that the EEG has a very low diagnostic yield in patients presenting with unexplained TLOC. EEG was helpful in diagnosis of 1 of 2 cases, while a seizure diagnosis was made on clinical grounds in 22 of 23 cases. The high mortality associated with TLOC almost exclusively affected multimorbid patients above 65 years, suggesting high risk of death from an underlying medical cause and not from seizures in this group of patients.
- 9 October 2013
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 84 (11) , e2.173-e2
THE VALUE OF EEG IN THE INVESTIGATION OF UNEXPLAINED SYNCOPE IN A GENERAL HOSPITAL POPULATION
Background Many physicians request EEG in order to differentiate between syncope and seizure in individuals presenting with transient loss of consciousness (TLOC). This is particularly the case in people taken to hospital following a collapse, where a witness account is not always available. Purpose We aim to investigate the usefulness of EEG in the assessment of unexplained TLOC in a large, unselected group of patients presenting in an emergency department. We also assess the risk of seizure development and clinical course following initial presentation. Methods We retrospectively reviewed referral forms of all routine and urgent EEGs performed at Sir Charles Gairdner Hospital, Perth, Western Australia between April 2010 to November 2011 to identify recordings performed for the investigation of suspected syncope or TLOC. Cases with identifiable cause at initial assessment, and cases suggestive of seizure, previous diagnosis of epilepsy and falls without loss of consciousness were excluded. Diagnosis at discharge and EEG reports were obtained through electronic patient records, EEG archive, and case notes as required. EEGs were classified as normal, abnormal (non–epileptiform abnormalities only), and showing definite epileptiform discharges (EDs). Detailed clinical information including subsequent development of seizures or death was collected for a subgroup of patients with 1–year follow–up after first presentation across all hospitals in the greater Perth area through health electronic linkage. General practitioners and patients were also contacted in order to obtain additional information as needed. The death rate and standardised mortality ratio (SMR) were calculated according to standard methods based on life table 2008–2010 of the Australian Bureau of Statistics. Results We identified 197 cases with unexplained TLOC (age range 18–98 years). No further clinical information was available for 11 cases. The EEG was abnormal in 1/3 of all cases, and in 50% of those over 65 years. EDs were identified in 2 patients (1%); of those, a diagnosis of seizure was made in one patient who was subsequently started on antiepileptic treatment, with no final diagnosis made in the other. Diagnosis at discharge was made in 129 cases (65%) with 23 (18%) of those receiving a seizure diagnosis. The 1–year follow up group consisted of 82 patients (age range 20–95 years); 52 (63%) people were multimorbid (defined as having ≥2 conditions). None of the patients without a seizure diagnosis presented with seizures during follow–up. During this period there were 11 deaths (age range 30–94 years), all in multimorbid people, and none in people with seizure diagnosis. The case fatality rate was 13.4% and SMR 4.27 (95% Fisher's exact CI, 2.13–7.42). Discussion This study demonstrates that the EEG has a very low diagnostic yield in patients presenting with unexplained TLOC. EEG was helpful in diagnosis of 1 of 2 cases, while a seizure diagnosis was made on clinical grounds in 22 of 23 cases. The high mortality associated with TLOC almost exclusively affected multimorbid patients above 65 years, suggesting high risk of death from an underlying medical cause and not from seizures in this group of patients.
- 1 October 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (14) , 1252-1256
Postictal generalized EEG suppression
Objective: To determine the consistency and facilitating cofactors of postictal generalized EEG suppression (PGES) of >20 seconds after convulsive seizures (CS), a suggested predictor of sudden unexpected death in epilepsy risk. Methods: We retrospectively reviewed video-EEG data of people with ≥2 recorded CS. Presence and duration of PGES were assessed by 2 independent observers blinded to patient status. Intraindividual consistency of PGES >20 seconds was determined and correlations with clinical characteristics were analyzed after correction for individual effects and the varying number of seizures. Results: One hundred fifty-four seizures in 59 people were analyzed. PGES >20 seconds was found in 37 individuals (63%) and 57 (37%) of CS. The proportion of persons in whom PGES occurred consistently (presence or absence of PGES >20 seconds in all CS) was lower in those with more CS. PGES of >20 seconds was more frequent in seizures arising from sleep (odds ratio 3.29, 95% confidence interval 1.21–8.96) and when antiepileptic medication was tapered (odds ratio 4.80, 95% confidence interval 1.27–18.14). Conclusion: Apparent PGES consistency was less frequent in people with more CS recorded, suggesting that PGES is an inconsistent finding in any one individual. Thus, we believe that PGES >20 seconds is not a reliable predictor of sudden unexpected death in epilepsy. Sleep and antiepileptic drug reduction appear to facilitate the occurrence of PGES.
- 1 October 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (14) , 1252-1256
Postictal generalized EEG suppression
Objective: To determine the consistency and facilitating cofactors of postictal generalized EEG suppression (PGES) of >20 seconds after convulsive seizures (CS), a suggested predictor of sudden unexpected death in epilepsy risk. Methods: We retrospectively reviewed video-EEG data of people with ≥2 recorded CS. Presence and duration of PGES were assessed by 2 independent observers blinded to patient status. Intraindividual consistency of PGES >20 seconds was determined and correlations with clinical characteristics were analyzed after correction for individual effects and the varying number of seizures. Results: One hundred fifty-four seizures in 59 people were analyzed. PGES >20 seconds was found in 37 individuals (63%) and 57 (37%) of CS. The proportion of persons in whom PGES occurred consistently (presence or absence of PGES >20 seconds in all CS) was lower in those with more CS. PGES of >20 seconds was more frequent in seizures arising from sleep (odds ratio 3.29, 95% confidence interval 1.21–8.96) and when antiepileptic medication was tapered (odds ratio 4.80, 95% confidence interval 1.27–18.14). Conclusion: Apparent PGES consistency was less frequent in people with more CS recorded, suggesting that PGES is an inconsistent finding in any one individual. Thus, we believe that PGES >20 seconds is not a reliable predictor of sudden unexpected death in epilepsy. Sleep and antiepileptic drug reduction appear to facilitate the occurrence of PGES.